Answer
Dec 12, 2024 - 12:47 PM
Intrarosa, a medication used to treat postmenopausal women experiencing moderate to severe dyspareunia, can be expensive due to factors such as research and development costs, the regulatory process, and market exclusivity. Additionally, manufacturing complexities and the relatively small target population for this specific treatment can also contribute to its high price.
